Valuation: Azenta, Inc.

Market Cap 1.27B 1.12B 1.04B 953M 1.79B 122B 1.81B 12.34B 4.82B 60.07B 4.76B 4.66B 208B P/E 2026 *
-7.51x
P/E 2027 * 115x
Enterprise Value 1.27B 1.12B 1.04B 953M 1.79B 122B 1.81B 12.34B 4.82B 60.07B 4.76B 4.66B 208B EV / Sales 2026 *
2.11x
EV / Sales 2027 * 2.01x
Free-Float
76.62%
Yield 2026 *
-
Yield 2027 * -
1 day+0.55%
1 week+4.80%
Current month+7.84%
1 month+7.92%
3 months+9.42%
6 months-31.42%
Current year-17.26%
1 week 26.17
Extreme 26.17
28.34
1 month 24.24
Extreme 24.245
28.34
Current year 15.93
Extreme 15.93
41.73
1 year 15.93
Extreme 15.93
41.73
3 years 15.93
Extreme 15.93
69.16
5 years 15.93
Extreme 15.93
124.79
10 years 12.05
Extreme 12.05
124.79
Manager TitleAgeSince
Chief Executive Officer 45 2024-09-08
Director of Finance/CFO 49 2024-11-30
Chief Tech/Sci/R&D Officer - 2009-10-31
Director TitleAgeSince
Director/Board Member 64 2013-06-27
Director/Board Member 50 2020-04-02
Chairman 72 2024-01-29
Date Insider Type Main position Quantity % Market Cap.
5/18/26 Buy

Director

10,000 0.0217%
5/15/26 Tax

General Counsel

-3,621 0.0079%
4/28/26 Free

President Multiomics

17,790 0.0386%
Change 5-day change 1-year change 3-year change Capi.($)
+0.55%+4.80%-20.07%-40.41% 1.27B
+0.39%-0.46%-0.67%+11.26% 47.74B
-0.61%+4.26%+396.16%+647.20% 39.98B
0.00%+4.93%+11.81%+55.56% 36.23B
+2.48%+4.57%+7.05%-5.05% 35.59B
+0.62%+3.53%+5.41%+42.19% 27.91B
-2.00%+11.64%+31.71%+136.81% 16.45B
-0.17%+0.66% - - 16.71B
+0.72%-3.24%+3.03%+8.15% 13.21B
+1.82%+1.56%-9.75%-30.15% 12.93B
Average +0.38%+2.97%+47.19%+91.73% 24.8B
Weighted average by Cap. +0.39%+2.95%+73.70%+135.50%

Financials

2026 *2027 *
Net sales 600M 528M 491M 451M 847M 57.58B 859M 5.84B 2.28B 28.43B 2.25B 2.21B 98.28B 630M 554M 516M 474M 889M 60.43B 901M 6.13B 2.39B 29.84B 2.37B 2.31B 103B
Net income -159M -140M -130M -120M -225M -15.26B -228M -1.55B -605M -7.54B -597M -585M -26.05B 17.3M 15.21M 14.16M 13M 24.41M 1.66B 24.74M 168M 65.72M 819M 64.94M 63.54M 2.83B
Net Debt - -
Logo Azenta, Inc.
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.
Employees
2,900
Date Price Change Volume
26-07-27 $27.52 +0.55% 710,666
26-07-24 $27.37 -3.29% 698,115
26-07-23 $28.30 +4.20% 607,300
26-07-22 $27.16 +2.14% 498,555
26-07-21 $26.59 +1.26% 557,152
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
27.52USD
Average target price
27.80USD
Spread / Average Target
+1.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AZTA Stock